Your browser doesn't support javascript.
Collateral damage of the COVID-19 pandemic on the management of homozygous familial hypercholesterolemia.
Kayikcioglu, Meral; Tokgozoglu, Lale; Tuncel, Ozlem Kuman; Pirildar, Sebnem; Can, Levent.
  • Kayikcioglu M; Department of Cardiology, Ege University Medical Faculty, Izmir, Turkey. Electronic address: meral.kayikcioglu@gmail.com.
  • Tokgozoglu L; Department of Cardiology, Hacettepe University Medical Faculty, Ankara, Turkey.
  • Tuncel OK; Department of Psychiatry, Ege University Medical Faculty, Izmir, Turkey.
  • Pirildar S; Department of Psychiatry, Ege University Medical Faculty, Izmir, Turkey.
  • Can L; Department of Psychiatry, Ege University Medical Faculty, Izmir, Turkey.
J Clin Lipidol ; 15(2): 381-382, 2021.
Article in English | MEDLINE | ID: covidwho-1260769

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Component Removal / COVID-19 / Hyperlipoproteinemia Type II Type of study: Diagnostic study / Observational study Limits: Humans Language: English Journal: J Clin Lipidol Journal subject: Biochemistry / Metabolism Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Component Removal / COVID-19 / Hyperlipoproteinemia Type II Type of study: Diagnostic study / Observational study Limits: Humans Language: English Journal: J Clin Lipidol Journal subject: Biochemistry / Metabolism Year: 2021 Document Type: Article